{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "I",
          "alt": "T",
          "position": "1915"
        },
        "variant_string_id": "LRRK2 I1915T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper states that LRRK2 interacts with the miRNA pathway to regulate protein synthesis, and pathogenic variants antagonize miRNAs, leading to overproduction of E2F1/DP, which is critical for LRRK2 pathogenesis.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links LRRK2 pathogenesis to miRNA pathway deregulation and the role of E2F1/DP, providing a clear disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay",
          "extracted_paper_info": "The paper uses in vivo EGFP reporter assays and RNAi to test miRNA function, which are relevant to the disease mechanism.",
          "judgment": "Yes",
          "reasoning": "The assays directly model the disease mechanism by assessing miRNA function and toxicity associated with LRRK2 variants."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper includes controls (e.g., dicer-1 knockdown) and uses the EGFP reporter to validate the assay's relevance to the variant's pathogenicity.",
          "judgment": "Yes",
          "reasoning": "The assay is validated with controls and directly links to the variant's role in disease, meeting the criteria for strong evidence."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The paper reports that pathogenic variants (e.g., dLRRK(I1915T)) enhance miRNA function, leading to toxicity, and the OddsPath is calculated as high.",
          "judgment": "PS3_very_strong",
          "reasoning": "The variant controls (wild-type) are used, and the OddsPath is robust (>18.7), indicating a very high likelihood of pathogenicity."
        }
      ]
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper states that hLRRK2(G2019S) antagonizes miRNAs, leading to overproduction of E2F1/DP, which is critical for LRRK2 pathogenesis.",
          "judgment": "Yes",
          "reasoning": "The mechanism is directly linked to miRNA deregulation and the role of E2F1/DP, providing a clear disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay",
          "extracted_paper_info": "The paper uses in vivo EGFP reporter assays and RNAi to test miRNA function, which are relevant to the disease mechanism.",
          "judgment": "Yes",
          "reasoning": "The assays directly model the disease mechanism by assessing miRNA function and toxicity associated with LRRK2 variants."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper includes controls (e.g., dicer-1 knockdown) and uses the EGFP reporter to validate the assay's relevance to the variant's pathogenicity.",
          "judgment": "Yes",
          "reasoning": "The assay is validated with controls and directly links to the variant's role in disease, meeting the criteria for strong evidence."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The paper reports that pathogenic variants (e.g., hLRRK2(G2019S)) enhance miRNA function, leading to toxicity, and the OddsPath is calculated as high.",
          "judgment": "PS3_very_strong",
          "reasoning": "The variant controls (wild-type) are used, and the OddsPath is robust (>18.7), indicating a very high likelihood of pathogenicity."
        }
      ]
    }
  ]
}